Olga Shevetz

Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study

Eli Muchtar, Moshe E. Gatt, Ory Rouvio et al. · British Journal of Haematology · 2015 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A phase I‐<scp>II</scp> clinical trial of the anti‐<scp>CD</scp>74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: <i>A patient based approach</i>

Michal Haran, Vita Mirkin, Andrei Braester et al. · British Journal of Haematology · 2017 · 35 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?

Merav Leiba, Adrian Duek, Ninette Amariglio et al. · Genes Chromosomes and Cancer · 2016 · 32 citations

Medicine, Genetics, Hematology +15

Outcomes of light‐chain amyloidosis patients treated with first‐line bortezomib: a collaborative retrospective multicenter assessment

Moshe E. Gatt, Izhar Hardan, Evgeni Chubar et al. · European Journal Of Haematology · 2015 · 16 citations

Medicine, Hematology, Oncology +13